Defining the origin of p53 binding selectivity by dissecting cancer-associated from tissue specific differences, would help to understand the fundamental mechanisms regulating p53 interactions with the human genome in the context of chromatin and changing epigenome. The gene discussed is TP53; the disease is cancer.